205 related articles for article (PubMed ID: 28102436)
21. Outcomes after urethroplasty for radiotherapy induced bulbomembranous urethral stricture disease.
Hofer MD; Zhao LC; Morey AF; Scott JF; Chang AJ; Brandes SB; Gonzalez CM
J Urol; 2014 May; 191(5):1307-12. PubMed ID: 24333513
[TBL] [Abstract][Full Text] [Related]
22. Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.
Putora PM; Engeler D; Haile SR; Graf N; Buchauer K; Schmid HP; Plasswilm L
Strahlenther Onkol; 2016 Mar; 192(3):182-9. PubMed ID: 26713323
[TBL] [Abstract][Full Text] [Related]
23. Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer.
Mayer EN; Tward JD; Bassett M; Lenherr SM; Hotaling JM; Brant WO; Lowrance WT; Myers JB
BJU Int; 2017 May; 119(5):700-708. PubMed ID: 27469289
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis.
Awad MA; Gaither TW; Osterberg EC; Murphy GP; Baradaran N; Breyer BN
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):168-174. PubMed ID: 29296018
[TBL] [Abstract][Full Text] [Related]
25. High-dose-rate strictures: a theory of cancer meets anatomic reality.
McLaughlin PW; Narayana V
Brachytherapy; 2013; 12(3):199-201. PubMed ID: 23541480
[No Abstract] [Full Text] [Related]
26. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer.
Tharp M; Hardacre M; Bennett R; Jones WT; Stuhldreher D; Vaught J
Brachytherapy; 2008; 7(3):231-6. PubMed ID: 18579446
[TBL] [Abstract][Full Text] [Related]
27. Urethroplasty after radiation therapy for prostate cancer.
Glass AS; McAninch JW; Zaid UB; Cinman NM; Breyer BN
Urology; 2012 Jun; 79(6):1402-5. PubMed ID: 22521189
[TBL] [Abstract][Full Text] [Related]
28. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
29. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
[TBL] [Abstract][Full Text] [Related]
30. Endourethral brachytherapy for prevention of recurrent urethral stricture following internal urethrotomy--first clinical experiences and results.
Olschewski T; Kröpfl D; Seegenschmiedt MH
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1400-4. PubMed ID: 14630279
[TBL] [Abstract][Full Text] [Related]
31. Urethroplasty for high risk, long segment urethral strictures with ventral buccal mucosa graft and gracilis muscle flap.
Palmer DA; Buckley JC; Zinman LN; Vanni AJ
J Urol; 2015 Mar; 193(3):902-5. PubMed ID: 25261802
[TBL] [Abstract][Full Text] [Related]
32. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
[TBL] [Abstract][Full Text] [Related]
33. Expanded use of a dorsal onlay augmented anastomotic urethroplasty with buccal mucosa for long segment bulbar urethral strictures: analysis of outcomes and complications.
Hoy NY; Kinnaird A; Rourke KF
Urology; 2013 Jun; 81(6):1357-61. PubMed ID: 23522293
[TBL] [Abstract][Full Text] [Related]
34. Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization.
Akimoto T; Katoh H; Kitamoto Y; Shirai K; Shioya M; Nakano T
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1360-6. PubMed ID: 16406395
[TBL] [Abstract][Full Text] [Related]
35. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
Ishiyama H; Kitano M; Satoh T; Kotani S; Uemae M; Matsumoto K; Okusa H; Tabata K; Baba S; Hayakawa K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):23-8. PubMed ID: 19243900
[TBL] [Abstract][Full Text] [Related]
36. High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity.
Monroe AT; Faricy PO; Jennings SB; Biggers RD; Gibbs GL; Peddada AV
Brachytherapy; 2008; 7(1):7-11. PubMed ID: 18299109
[TBL] [Abstract][Full Text] [Related]
37. [Endourethral brachytherapy for the prevention of recurrent strictures following internal urethrotomy].
Kröpfl D; Olschewski T; Seegenschmiedt MH
Urologe A; 2004 Oct; 43(10):1254-61. PubMed ID: 15278200
[TBL] [Abstract][Full Text] [Related]
38. Relationship between the dose to the bulbomembranous urethra and stricture after high dose-rate brachytherapy for prostate cancer: Matched-pair analysis.
Sekiguchi A; Tsumura H; Kawakami S; Satoh T; Iwamura M; Ishiyama H
Int J Urol; 2019 Sep; 26(9):938-939. PubMed ID: 31256422
[No Abstract] [Full Text] [Related]
39. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer.
Khor R; Duchesne G; Tai KH; Foroudi F; Chander S; Van Dyk S; Garth M; Williams S
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):679-85. PubMed ID: 22954770
[TBL] [Abstract][Full Text] [Related]
40. Urethral strictures after radiation therapy for prostate cancer.
Moltzahn F; Dal Pra A; Furrer M; Thalmann G; Spahn M
Investig Clin Urol; 2016 Sep; 57(5):309-15. PubMed ID: 27617311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
